Eric Halioua, Co-founder & Chief Executive Officer, MBA, M.Sc
Eric Halioua is a serial entrepreneur with strong managerial, technological, fund-raising and deal-making experience. He is as well President of PDC*Line Pharma, Board member of the companies, Bioxodes (Belgium), and member of the strategic advisory board of OncoDNA (Belgium), Innobiochips (France), and the CER Groupe (Belgium). Eric has been CEO at the biotechnology company Promethera Biosciences. Under his leadership, the company raised successfully more than 65M€ in capital, grants and loans. He was as well co-founder of two biotechnology companies called Myosix and Murigenetics. Myosix has been acquired by Genzyme/Sanofi mid-2002. During 11 years, he has been principal of the international life sciences practice of Arthur D. Little based in Paris and Boston. Eric worked as well as a project leader in the corporate R&D centre of Astra-Zeneca in UK. Eric Holds two master degrees (DEA and Magistère) in Pharmacology and Molecular Biology and a MBA from ESSEC business school (Paris, France).
Bruno Ferré, Co-founder & Medical Director, MD
Dr. Bruno Ferré is a full-time Orthopaedic Surgeon specialized in Foot & Ankle Surgery at the Medical and Surgical Orthopaedic Institute of Monaco (IM2S). He is the Head of the Medical Informatics Department at IM2S. Dr Bruno Ferré is Past President (2015-2016) of the French Association of Foot Surgery (AFCP) and a board member of the French Society of Orthopaedic Surgery and Traumatology (SOFCOT). Dr Bruno Ferré received his medical degree in 1978 and completed specialty training in Orthopaedic Surgery in 1983 at Nantes. He has wide ranging research interests across clinical biomechanics, foot and ankle surgery and computational modeling. Dr. Bruno Ferré has authored numerous research publications, as well as book chapters covering various surgical treatments of foot and ankle conditions and delivered numerous invited lectures internationally.
Thibaut Leemrijse, Co-founder & Medical Director, MD
Dr. Thibaut Leemrijse is a full-time orthopaedic surgeon, specialised in foot and ankle surgery. After graduating in June 1999, he won the 1st Prize of the European Foot and Ankle Society EFAS-EFFORT and performed a fellowship with several leading persons with the same interest in foot and ankle surgery For five years, he was the head of the department for foot and ankle pathologies in CHU Bichat (Paris, France). This was followed by 7 years as clinical Professor at St Luc University Hospital (UCL, Brussel, Belgium) and head of the unit of diabetic foot. In 2010, he was the co-founder of the “Foot and Ankle Institute” in Brussels (Belgium) and has now a team of three other surgeons and a research manager. It is the largest and leading group in Belgium with more than 12,000 patients and 1200 surgical procedures a year. Dr. Leemrijse is member of the Medical Training Centre in Luxembourg. In terms of research, he is involved in the development and design of many products in foot surgery with several patents. He has published various books on the pathology of the forefoot, is co-author on the Diabetic Foot Book, director of a textbook on pathology of the foot and ankle at Elsevier Masson. He has published 28 international papers in peer reviewed journals and has participated in more than 50 book chapters.
Paul-André Deleu, Podiatrist, MSc
Paul-André Deleu is a Podiatrist by first degree and works as Clinical Scientist at the Foot & Ankle Institute in Brussels (Belgium). He initiates, coordinates, and supervises research on the foot and ankle pathologies. His research interests are focused on foot and ankle surgery, foot orthoses, foot and ankle biomechanics and therapeutic footwear. He has authored numerous research publications, as well as book chapters covering various foot and ankle conditions and delivered numerous lectures internationally. He is an active member of the International Society of Biomechanics and of the International Foot and Ankle Biomechanics Community.
Paul-André is an invited lecturer at the Parnasse-Isei School of Podiatry in Brussels (Belgium) and continues to teach into a range of undergraduate and postgraduate courses for both allied health professionals and medical students across different universities.
Guillaume de Viron, Chief Financial Officer
6 years of process optimisation within Deloitte Consulting and 10 years as CFO for different start-ups in Biotech (Artelis, Kitozyme, Masthercell, Univercells, OncoDNA,…).
He is also the founder of belean.net a shared service to master the growth of start-ups.
Jesu Kiran Spurgen, Medical Image Analyst, M.Sc
Jesu completed his degree in Electronics and Communication Engineering (Karunya University, Coimbatore, India 2006-2010) and is a trained Medical Systems Engineer (Otto-von-Guericke University, Magdeburg, Germany, 2012-2014) with a postgraduate training in Advanced Medical Imaging (KU Leuven, Belgium 2015-2016). He recently defended his thesis on Image based localization of electrical activity in transcranial magnetic stimulation in brain tumour neurosurgery for his postgraduate diploma. He has experience working with medical images from across modalities (CT, MRI) and his interests include working on the pre- & post-processing techniques used in medical image processing.
Andrea Stenti, Senior Biomechanical Simulation Engineer, PhD
Andrea holds a master degree in aeronautical engineering (Università degli Studi di Napoli Federico II, Italy) and a PhD in mechanical engineering (Katholieke Universiteit Leuven, Belgium). He has 10 years’ experience in the automotive industry as an acoustic and vibration simulation expert and project manager (Robert Bosch Produktie N.V. Tienen, Belgium; Robert Bosch GmbH, Bühlertal, Germany).
Andrea is specialized in developing models for product optimization and risk assessment, focusing on the structural dynamic simulation of complex assemblies involving severe non-linearities: material, geometrical and contact related.
Sheng-Yi Ye, Biomechanical Simulation Engineer, M.Sc.
Sheng-Yi obtained his Master degree in Electromechanical Engineering at the Ecole Polytechnique de Louvain (Université Catholique de Louvain, Louvain-la-Neuve, Belgium 2011-2016) and showed an high interest in Multibody Simulation. Moreover, he recently defended his Master Thesis on Railway Vehicles Multibody Simulations in order to speed up their nominal speed. Since he is interested in medical applications, he also oriented his education in that way. As such, he had the opportunity to work with the University Clinics (Cliniques Universitaires Saint-Luc, Brussels, Belgium 2016-2017) on a knee’s kinematics measurement device and a skin thermal Finite Element Model.
Ang-Xiao Fan, Finite Element Engineer, PhD
Ang-Xiao obtained her engineer diploma (Diplôme d’Ingénieur) in Mechanical Engineering and Development (Institut National des Sciences Appliquées de Lyon, France) in 2013 and a master degree in biomechanics in parallel. She gained a PhD degree in biomechanical engineering (Université de Technologie de Compiègne, France) in 2016.
She is interested in the application of mechanical methodology in solutions to biomedical problems, especially the Finite Element Analysis via numeric modeling and simulation.
Yolande Aglave Office Manager
Yolande holds a complementary master degree in Labour Sciences (Université Catholique, Louvain-La-Neuve). Before, she graduated in the Marketing. She also obtained some other certificates (Business analyst, communication…).
She supported several start-ups in the administrative implemention of the operations (HR, commercial, legal, IT, …) and organizational processes.
Elisa Bigaré Knowledge Base Manager
Elisa is physiotherapist by first degree and holds a master degree in Public Health (ULB, Belgium).
She works nearly 10 years in hospital and pharmaceutical environments, as coordinator of locomotor system allografts at the University Tissue Bank of St Luc Hospital (UCL, Belgium) and as Clinical Research Associate/ Clinical Study Manager in the development of Stem Cell Therapy.
Elisa joined Digital Orthopaedics in June 2017 as Clinical Knowledge Base Manager to support the development of the CDSS and conduct CDSS-specific clinical trials.